Sabin Listed by nokoyawa Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

Ransomware groups continue to target healthcare and diagnostics providers worldwide, drawn by the sensitivity of medical data and the operational pressure such organisations face to restore services quickly. In that broader pattern, the listing of a major Brazilian laboratory group on a ransomware leak site in April 2023 fits a familiar and concerning trend.

On 20 April 2023, Sabin was reported as listed by the nokoyawa ransomware group. Public detail is limited: the number of people affected remains unknown, and the only data description available is that internal files were allegedly exfiltrated in a ransomware attack. The listing itself is a claim by the group. For patients, employees and partners of a leading diagnostics firm, even an unverified claim of this kind raises practical questions about what may have been exposed and what steps to take.

Inside the incident

According to the available record, Sabin was listed by the nokoyawa ransomware group on or around 20 April 2023. The report states that internal files were exfiltrated in a ransomware attack. No confirmed figure for the number of individuals affected has been published. Timing of the initial intrusion, the precise method of access, the volume of data taken, and any ransom demand or negotiation outcome are not disclosed in the public summary.

What is known is therefore narrow: a claim on a ransomware leak site that Sabin Laboratory data had been stolen, coupled with the characterisation of the material as internal files obtained during a ransomware incident. No independent confirmation of the full scope or of any subsequent data publication is contained in the facts provided. In the absence of further official disclosure, the scale and exact contents of any breach remain unconfirmed.

Inside nokoyawa

Nokoyawa is a ransomware operation that has appeared in public reporting since roughly 2022. Like many contemporary groups, it has typically combined encryption of victim systems with data theft, using the threat of publication on a dedicated leak site to increase pressure. The group has been associated with attacks across multiple sectors and geographies, often relying on common initial-access routes such as exploited vulnerabilities, compromised credentials or phishing, though specific tactics vary by incident.

Public analyses have described nokoyawa as using double-extortion methods: locking systems and simultaneously exfiltrating files so that non-payment can be followed by leaks or auction-style threats. The group’s leak-site listings are claims made by the operators; they do not by themselves constitute independent verification that every named organisation was fully compromised or that every asserted file set was authentic. In this case, the facts state only that Sabin was listed and that internal files were described as exfiltrated; no further statements attributed to nokoyawa about this victim are included in the record.

Who is Sabin?

Sabin Laboratory is described as one of the leading medical diagnostics companies in Brazil, known for a wide range of laboratory tests and for an emphasis on customer service and organisational culture. Organisations of this type sit at the centre of clinical decision-making: they receive samples, generate results, and hold records that link patients to tests, referring physicians and sometimes insurers or employers.

A breach affecting such a provider is consequential because diagnostics data is both personal and clinically sensitive. Even when the precise contents of a theft are unconfirmed, the mere possibility that internal laboratory files left the organisation’s control creates lasting concern for confidentiality, trust and regulatory obligations under Brazilian data-protection rules and health-sector standards.

What data was at risk

The facts name the exposed material only as “internal files exfiltrated in a ransomware attack.” No inventory of specific data categories—such as patient names, test results, identification numbers, employee records or financial documents—has been published in the available summary. The number of people affected is unknown.

Medical diagnostics companies typically hold patient identifiers, contact details, laboratory orders and results, referring-clinician information, and internal operational documents. They may also retain billing or insurance-related data and staff records. Because the exact contents in this incident are unconfirmed, it is not possible to state as fact which of these categories, if any, were included in the material the group claims to have taken. Readers should treat any detailed assertion about specific fields as unverified unless Sabin or a competent authority later confirms it.

The real-world impact

For individuals, the primary risks associated with a laboratory-related incident are misuse of personal and health information: targeted phishing that references real tests or clinics, identity fraud if identity documents or numbers were present, or embarrassment and discrimination if sensitive results became public. Even when data is not immediately published, the possibility of later leaks or secondary sales keeps the risk alive for years.

For the organisation, consequences can include operational disruption during containment and recovery, regulatory scrutiny, contractual notifications to partners, and erosion of patient confidence. Because people-affected counts and precise data types remain undisclosed, the full extent of these impacts cannot be quantified from the public record alone. The prudent stance is to assume that anyone who has used Sabin’s services or worked with the company may wish to treat the claim seriously until clearer information emerges.

Were you affected?

If you are a patient, employee or partner of Sabin, monitor official statements from the company and from Brazilian data-protection or health authorities. Watch financial and medical accounts for unusual activity, be cautious of unsolicited messages that reference laboratory visits or results, and consider placing fraud alerts where appropriate. Change passwords on related accounts if you reuse credentials, and enable multi-factor authentication wherever it is offered.

You can also run a free exposure scan of your email address to check whether your information has already surfaced in known breach data sets. That step does not confirm or rule out involvement in this specific incident, but it can help you spot credentials or personal details that have appeared elsewhere and take follow-up action.

AICompiled with AI assistance from public sources and published under our editorial standards.